Table 3.
Clinical Characteristics (<45 years age group).
| Age (years) | 24.6 (21.5, 28.9) |
| BMI (kg/m2) | 24.2 (21.6, 28.5) |
| Duration of feminizing therapy (months) | 23.8 (15.2, 32.4) |
| Estradiol dose | Oral 6 (4-8) mg |
| Estradiol concentration (pmol/L) | 328 (237, 434) |
Median (IQR) are shown. BMI, body mass index.